Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis

BACKGROUND: Anemia is one of severe complications in the perioperative period of total hip arthroplasty (THA). Erythropoietin (EPO) has been considered to improve patients’ anemia state, but its efficiency and safety remains controversial. METHODS: A total of 152 patients who underwent total hip art...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Ru-xin, Bai, Chao-wen, Zhang, Le, Huang, Chao-ran, Pan, Sheng, Zhang, Xing-chen, Zhu, Zheng-ya, Zheng, Xin, Guo, Kai-jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678274/
https://www.ncbi.nlm.nih.gov/pubmed/33213494
http://dx.doi.org/10.1186/s13018-020-02083-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678274/
https://www.ncbi.nlm.nih.gov/pubmed/33213494
http://dx.doi.org/10.1186/s13018-020-02083-w

Ejemplares similares